The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments

被引:425
|
作者
Mahnke, K
Guo, M
Lee, S
Sepulveda, H
Swain, SL
Nussenzweig, M
Steinman, RM
机构
[1] Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA
[2] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA
[3] Trudeau Inst Inc, Saranac Lake, NY 12983 USA
来源
JOURNAL OF CELL BIOLOGY | 2000年 / 151卷 / 03期
关键词
dendritic cell; antigen presentation; DEC-205; MHC class II; endocytosis;
D O I
10.1083/jcb.151.3.673
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Many receptors for endocytosis recycle into and out of cells through early endosomes. We now find in dendritic cells that the DEC-205 multilectin receptor targets late endosomes or lysosomes rich in major histocompatibility complex class II (MHC II) products, whereas the homologous macrophage mannose receptor (MMR), as expected, is found in more peripheral endosomes. To analyze this finding, the cytosolic tails of DEC-205 and MMR were fused to the external domain of the CD16 Fc gamma receptor and studied in stable L cell transfectants. The two cytosolic domains each mediated rapid uptake of human immunoglobulin (Ig)G followed by recycling of intact CD16 to the cell surface. However, the DEC-205 tail recycled the CD16 through MHC II-positive late endosomal/lysosomal vacuoles and also mediated a 100-fold increase in antigen presentation. The mechanism of late endosomal targeting, which occurred in the absence of human IgG, involved two functional regions: a membrane-proximal region with a coated pit sequence for uptake, and a distal region with an EDE triad for the unusual deeper targeting, Therefore, the DEC-205 cytosolic domain mediates a new pathway of receptor-mediated endocytosis that entails efficient recycling through late endosomes and a greatly enhanced efficiency of antigen presentation to CD4(+) T cells.
引用
收藏
页码:673 / 683
页数:11
相关论文
共 50 条
  • [31] A role for the Hsp90 molecular chaperone family in antigen presentation to T lymphocytes via major histocompatibility complex class II molecules
    Rajagopal, D
    Bal, V
    Mayor, S
    George, A
    Rath, S
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (04) : 828 - 841
  • [32] Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo
    Brocker, T
    Riedinger, M
    Karjalainen, K
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03): : 541 - 550
  • [33] TARGETING MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES TO THE CELL-SURFACE BY INVARIANT CHAIN ALLOWS ANTIGEN PRESENTATION UPON RECYCLING
    NIJENHUIS, M
    CALAFAT, J
    KUIJPERS, KC
    JANSSEN, H
    DEHAAS, M
    NORDENG, TW
    BAKKE, O
    NEEFJES, JJ
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (04) : 873 - 883
  • [34] PROCESSING OF VIABLE GROUP-A STREPTOCOCCI LEADS TO MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II PRESENTATION OF T-CELL EPITOPES FROM THE MAJOR PROTECTIVE ANTIGEN
    ROSSITER, BA
    ALFONSO, C
    KEHOE, MA
    ROBINSON, JH
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (05) : 1244 - 1247
  • [35] Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways
    Castellino, F
    Boucher, PE
    Eichelberg, K
    Mayhew, M
    Rothman, JE
    Houghton, AN
    Germain, RN
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (11): : 1957 - 1964
  • [36] MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II-RESTRICTED PRESENTATION OF AN INTERNALLY SYNTHESIZED ANTIGEN DISPLAYS CELL-TYPE VARIABILITY AND SEGREGATES FROM THE EXOGENOUS CLASS-II AND ENDOGENOUS CLASS-I PRESENTATION PATHWAYS
    LOSS, GE
    ELIAS, CG
    FIELDS, PE
    RIBAUDO, RK
    MCKISIC, M
    SANT, AJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (01): : 73 - 85
  • [37] Delivery of a MalE CD4+-T-cell epitope into the major histocompatibility complex class II antigen presentation pathway by Bordetella pertussis adenylate cyclase
    Loucká, J
    Schlecht, G
    Vodolánová, J
    Leclerc, C
    Sebo, P
    [J]. INFECTION AND IMMUNITY, 2002, 70 (02) : 1002 - 1005
  • [38] Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: Processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells
    Vlad, AM
    Muller, S
    Cudic, M
    Paulsen, H
    Otvos, L
    Hanisch, FG
    Finn, OJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (11): : 1435 - 1446
  • [39] Alternative Endogenous Protein Processing via an Autophagy-Dependent Pathway Compensates for Yersinia-Mediated Inhibition of Endosomal Major Histocompatibility Complex Class II Antigen Presentation
    Ruessmann, Holger
    Panthel, Klaus
    Koehn, Brigitte
    Jellbauer, Stefan
    Winter, Sebastian E.
    Garbom, Sara
    Wolf-Watz, Hans
    Hoffmann, Sigrid
    Grauling-Halama, Silke
    Geginat, Gernot
    [J]. INFECTION AND IMMUNITY, 2010, 78 (12) : 5138 - 5150
  • [40] BINDING OF T-CELL RECEPTOR TO MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II-PEPTIDE COMPLEXES AT THE SINGLE-CELL LEVEL RESULTS IN THE INDUCTION OF ANTIGEN UNRESPONSIVENESS (ANERGY)
    CELIS, E
    SAIBARA, T
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (12) : 3127 - 3134